51 related articles for article (PubMed ID: 2423547)
1. Postradioiodine Graves' management: The PRAGMA study.
Perros P; Basu A; Boelaert K; Dayan C; Vaidya B; Williams GR; Lazarus JH; Hickey J; Drake WM; Crown A; Orme SM; Johnson A; Ray DW; Leese GP; Jones TH; Abraham P; Grossman A; Rees A; Razvi S; Gibb FW; Moran C; Madathil A; Žarković MP; Plummer Z; Jarvis S; Falinska A; Velusamy A; Sanderson V; Pariani N; Atkin SL; Syed AA; Sathyapalan T; Nag S; Gilbert J; Gleeson H; Levy MJ; Johnston C; Sturrock N; Bennett S; Mishra B; Malik I; Karavitaki N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):664-675. PubMed ID: 35274331
[TBL] [Abstract][Full Text] [Related]
2. Adjuvant rituximab, a potential treatment for the young patient with Graves' hyperthyroidism (RiGD): study protocol for a single-arm, single-stage, phase II trial.
Cole M; Hynes AM; Howel D; Hall L; Abinun M; Allahabadia A; Barrett T; Boelaert K; Drake AJ; Dimitri P; Kirk J; Zammitt N; Pearce S; Cheetham T
BMJ Open; 2019 Jan; 9(1):e024705. PubMed ID: 30670519
[TBL] [Abstract][Full Text] [Related]
3. Radioiodine treatment of hyperthyroidism in cats: results of 165 cats treated by an individualised dosing algorithm in Spain.
Xifra P; Serrano SI; Peterson ME
J Feline Med Surg; 2022 Aug; 24(8):e258-e268. PubMed ID: 35748791
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting remission in hyperthyroid patients after low-dose I-131 therapy: 20 years retrospective study from a tertiary care hospital.
S SY; Padma S; Sundaram PS
Ann Nucl Med; 2024 Mar; 38(3):231-237. PubMed ID: 38277114
[TBL] [Abstract][Full Text] [Related]
5. Large method differences for free thyroid hormone assays in the hyperthyroid range can affect assessment of hyperthyroid status: Comparison of Abbott Alinity to Roche Cobas, Siemens Centaur and equilibrium dialysis LC-MS/MS.
Westbye AB; Aas FE; Dahl SR; Zykova SN; Kelp O; Dahll LK; Thorsby PM
Clin Biochem; 2023 Nov; 121-122():110676. PubMed ID: 37848158
[TBL] [Abstract][Full Text] [Related]
6. The characteristics of Grave's disease in children and adolescent patients in Al-Madinah Al-Munawwarah: A retrospective chart review.
Alradadi RS; Omar NA; Alhusayni RA; Almokhtar AM; Muhawish SF; Altaleb MM; Tawfiq SA; Alraddadi RM; Almalki RQ
Saudi Med J; 2023 Mar; 44(3):284-288. PubMed ID: 36940965
[TBL] [Abstract][Full Text] [Related]
7. Lithium carbonate as add-on therapy to radioiodine in the treatment on hyperthyroidism: a systematic review and meta-analysis.
Abd-ElGawad M; Abdelmonem M; Ahmed AE; Mohammed OM; Zaazouee MS; Assar A; Gadelkarim M; Afifi AM
BMC Endocr Disord; 2021 Apr; 21(1):64. PubMed ID: 33840391
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms and Treatment Options for Hyperthyroid-Induced Osteoporosis: A Narrative Review.
Branstetter RM; Islam RK; Toups CA; Parra AN; Lee Z; Ahmadzadeh S; Varrassi G; Shekoohi S; Kaye AD
Cureus; 2023 Nov; 15(11):e48798. PubMed ID: 38098934
[TBL] [Abstract][Full Text] [Related]
9. Deliberate self-harm in a patient with hyperthyroidism with acute psychosis.
Wong HH; Pang NTP
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34649855
[TBL] [Abstract][Full Text] [Related]
10. Changes in serum hepcidin according to thyrometabolic status in patients with Graves' disease.
Krygier A; Szczepanek-Parulska E; Filipowicz D; Ruchala M
Endocr Connect; 2020 Feb; 9(3):234-42. PubMed ID: 32069222
[TBL] [Abstract][Full Text] [Related]
11. Urticaria as a manifestation of hyperthyroidism.
Womack N; Jude E
Clin Case Rep; 2021 May; 9(5):e03620. PubMed ID: 34084471
[TBL] [Abstract][Full Text] [Related]
12. Differential Diagnosis of Thyrotoxicosis by Machine Learning Models with Laboratory Findings.
Kim J; Baek HS; Ha J; Kim MK; Kwon HS; Song KH; Lim DJ; Baek KH
Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741278
[TBL] [Abstract][Full Text] [Related]
13. Severe Hypothyroxinemia in a Young Adult with Carbimazole-Treated T3-Predominant Graves' Hyperthyroidism, Reversed with L-Thyroxine Loading Immediately Post-Total Thyroidectomy.
Chiang B; Kon YC
J ASEAN Fed Endocr Soc; 2021; 36(1):85-89. PubMed ID: 34177093
[TBL] [Abstract][Full Text] [Related]
14. Triiodothyronine predominant Graves' disease in a South-East Asian population: prevalence and clinical significance.
Yong AM; Tai ES; Wong ZW; Eng PH; Ho SC; Khoo DH
J Endocrinol Invest; 2001 Mar; 24(3):204-5. PubMed ID: 11314753
[No Abstract] [Full Text] [Related]
15. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
Chen JJ; Ladenson PW
J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
[TBL] [Abstract][Full Text] [Related]
16. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease and toxic multinodular goiter.
Gedik O; Ozdemir T; Akalin S
Isr J Med Sci; 1991 Jul; 27(7):361-4. PubMed ID: 1712765
[TBL] [Abstract][Full Text] [Related]
17. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
18. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
Larsen PR
J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
[TBL] [Abstract][Full Text] [Related]
19. Graves' Disease: Can It Be Cured?
Wiersinga WM
Endocrinol Metab (Seoul); 2019 Mar; 34(1):29-38. PubMed ID: 30912336
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
